Navigation Links
MDV Expands Team Pursuing Advances in Personalized Medicine
Date:11/20/2008

MENLO PARK, Calif., Nov. 20 /PRNewswire/ -- MDV-Mohr Davidow Ventures, a leading Silicon Valley venture capital firm, today announced the addition of Phyllis Whiteley and Dan Riskin to the firm as Executive-in-Residence and Entrepreneur-in-Residence, respectively. Each will pursue and develop start-up opportunities that provide healthcare providers and consumers more effective ways to manage health and wellness -- from prevention to diagnosis to the treatment of disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070702/AQM026LOGO)

"Phyllis and Dan bring important domain expertise and experience to the MDV team," said MDV General Partner Sue Siegel. "They will strengthen MDV's current investing activities in personalized medicine and expand our reach into new areas including health information systems, Health 2.0 businesses, and into the emerging area of consumer-driven medicine."

Phyllis Whiteley brings more than 20 years experience across academics, biotech, and pharma in research, development, business, and portfolio management. Most recently she worked with 5AM Ventures where she co-founded Anaphore, Inc. Prior to her work in venture capital, Whiteley was an Officer and Senior Vice President at Perlegen Sciences, Inc. Before Perlegen, she served as Vice President, Strategic Portfolio Management for F. Hoffman La Roche. During her ten years with Roche, she held various senior management positions. Prior to her Roche tenure, Whiteley was a senior research immunologist at Merck. She holds a Ph.D. in Pharmacology from Washington University, St. Louis, Missouri. Whiteley serves on several private company boards and is on the board of the Personalized Medicine Coalition.

Dan Riskin will focus on healthcare information systems and business models as an EIR (Entrepreneur-In-Residence). He brings a diverse background with 15 years of medical expertise and 20 years of IT experience. Prior to MDV, Riskin was the President of Interventional Dynamics Inc, a medical technology R&D firm. Prior to Interventional Dynamics, Riskin was in business development at Roche Diagnostics where he worked with MIT Media Lab and BodyMedia to create and commercialize an IT-based obesity management system. In 2005, Riskin was named one of the top 35 innovators under 35 by MIT's Technology Review.

Riskin is an acute care surgeon and intensivist. He earned a MBA with a focus in bioinformatics from MIT Sloan School of Management and completed the prestigious Biodesign Medical Technology Fellowship at Stanford in 2005. His medical training includes a MD from Boston University, surgical residency at UCLA, and a critical care fellowship at Stanford.

About MDV-Mohr Davidow Ventures

MDV-Mohr Davidow Ventures is a leading Silicon Valley-based venture capital firm that partners with exceptional entrepreneurs building breakthrough companies that disrupt incumbents or create new markets, principally through technology innovation. The firm invests in the areas of Cleantech, Information Technology, and Human Health. Category-leading life science companies funded by MDV include: Adamas Pharmaceuticals; Artemis Health; CardioDx; CELLective Diagnostics; Corventis; Crescendo Bioscience; Navigenics; Pacific Biosciences; ParAllele (AFFX); RainDance Technologies; Tethys Bioscience; The DNA Repair Company; and Ventus Medical. MDV has $2 billion under management. For more information, visit http://www.mdv.com.


'/>"/>
SOURCE MDV-Mohr Davidow Ventures
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Voler Expands Medical Device Design Capabilities
2. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
3. Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems
4. DuPont Expands Seed Production Capacity to Meet Growing Demand for Seed, Grain
5. AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
6. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
7. ALine, Inc. Expands Management, Adding Roger Anderson, Ph.D., as VP of Operations
8. Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations
9. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
10. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
11. Genstruct Expands Team with New VP of Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Amgen (NASDAQ: AMGN ) and ... submission of a Marketing Authorization Application (MAA) to the European ... Avastin ® (bevacizumab). The companies believe this submission is ... "The submission of ABP 215 to the EMA ... oncology portfolio," said Sean E. Harper , M.D., executive ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... PhUSE will build on the ... US Single Day Events (SDE) to organize a multiple-day US conference. The first ... Topics of the pharmaceutical and life sciences industry will cover industry standards, data ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, ... on their recent FDA Class II 510(k) clearance for their flagship medical device, ... commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. While other companies ...
Breaking Biology Technology:
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
Breaking Biology News(10 mins):